HCA Healthcare (NYSE:HCA) Given New $392.00 Price Target at Barclays

HCA Healthcare (NYSE:HCA - Get Free Report) had its price target dropped by equities researchers at Barclays from $396.00 to $392.00 in a research note issued on Friday,Benzinga reports. The firm presently has an "overweight" rating on the stock. Barclays's price target points to a potential upside of 10.68% from the company's previous close.

Other analysts also recently issued reports about the company. TD Cowen reduced their price objective on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a research report on Monday, October 28th. Morgan Stanley began coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 price target for the company. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the stock an "outperform" rating in a report on Wednesday, July 24th. Finally, Wolfe Research raised HCA Healthcare to a "strong-buy" rating in a research note on Thursday, August 29th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and an average price target of $379.17.

HCA Healthcare Price Performance

Shares of HCA traded down $1.87 during mid-day trading on Friday, reaching $354.16. 1,248,234 shares of the company's stock were exchanged, compared to its average volume of 1,179,302. The company has a 50-day simple moving average of $389.61 and a two-hundred day simple moving average of $356.03. The company has a market cap of $89.71 billion, a price-to-earnings ratio of 15.90, a PEG ratio of 1.39 and a beta of 1.68. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare has a 52-week low of $226.48 and a 52-week high of $417.14.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company's stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company's stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Institutional Trading of HCA Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of HCA. Terra Nova Asset Management LLC lifted its stake in HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company's stock worth $3,297,000 after purchasing an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its position in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company's stock valued at $171,000 after buying an additional 29 shares during the last quarter. Waldron Private Wealth LLC lifted its holdings in HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company's stock worth $683,000 after acquiring an additional 29 shares during the last quarter. Brookstone Capital Management raised its position in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company's stock worth $1,652,000 after purchasing an additional 30 shares during the period. Finally, UMB Bank n.a. boosted its position in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company's stock valued at $529,000 after purchasing an additional 30 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.